Efficacy and Safety of Liraglutide in Subjects With Type 1 Diabetes Undergoing Islet Cell Transplantation
Clinical trial NCT01206101 · TERMINATED
Trial details
- NCT number
- NCT01206101
- Sponsor
- Novo Nordisk A/S
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-21
- Primary completion
- 2013-06-03
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.